NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Johnson & Johnson (NYSE: JNJ)
JNJ Technical Analysis
4
As on 31st Oct 2017 JNJ Share Price closed @ 139.41 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 126.40 & Buy for SHORT-TERM with Stoploss of 134.52 we also expect STOCK to react on Following IMPORTANT LEVELS. |
JNJ Share Price
Open | 140.02 | Change | Price | % |
High | 140.26 | 1 Day | -0.59 | -0.42 |
Low | 138.98 | 1 Week | 0.00 | 0.00 |
Close | 139.41 | 1 Month | 2.98 | 2.18 |
Volume | 4825660 | 1 Year | 20.94 | 17.68 |
52 Week High 144.35 | 52 Week Low 109.32 |
NYSE USA Most Active Stocks
RAI | 65.40 | -2.23% |
EMC | 29.05 | 0.97% |
GE | 20.16 | -1.22% |
AKS | 4.59 | -21.54% |
PCS | 11.84 | -0.92% |
AMD | 10.98 | 0.83% |
WSH | 47.18 | -2.86% |
JNS | 14.17 | -0.56% |
XLS | 24.66 | -0.64% |
SWY | 35.10 | -0.11% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
JNJ Daily Charts |
JNJ Intraday Charts |
Whats New @ Bazaartrend |
JNJ Free Analysis |
|
JNJ Important Levels Intraday
SUPPORT | 0.00 |
SUPPORT | 0.00 |
RESISTANCE | 140.60 |
RESISTANCE | 140.11 |
SUPPORT | 138.71 |
SUPPORT | 138.22 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
JNJ Target for Month January
4th UP TARGET | 167.02 |
3rd UP TARGET | 158.17 |
2nd UP TARGET | 152.69 |
1st UP TARGET | 147.22 |
1st DOWN TARGET | 131.6 |
2nd DOWN TARGET | 126.13 |
3rd DOWN TARGET | 120.65 |
4th DOWN TARGET | 111.8 |
JNJ Weekly Target
4th UP TARGET | 0.00 |
3rd UP TARGET | 0.00 |
2nd UP TARGET | 0.00 |
1st UP TARGET | 0.00 |
1st DOWN TARGET | 0.00 |
2nd DOWN TARGET | 0.00 |
3rd DOWN TARGET | 0.00 |
4th DOWN TARGET | 0.00 |
JNJ Target for Year 2021
4th UP TARGET | 0 |
3rd UP TARGET | 0 |
2nd UP TARGET | 0 |
1st UP TARGET | 0 |
1st DOWN TARGET | 0 |
2nd DOWN TARGET | 0 |
3rd DOWN TARGET | 0 |
4th DOWN TARGET | 0 |
Johnson & Johnson ( NYSE USA Symbol : JNJ )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
JNJ Other Details
Segment | EQ | |
Market Capital | 99999997952.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers - Major | |
Offical website | > echo $website ; ?> |
JNJ Address
![]() |
One Johnson & Johnson Plaza New Brunswick, NJ 08933 United States Phone: 732-524-0400 |
JNJ Latest News
JNJ Business Profile
Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers a range of products used in the baby care, skin care, oral care, wound care, and women’s health fields, as well as nutritionals, over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON’S, AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LUBRIDERM, NEUTROGENA, RoC, VENDÔME, LISTERINE, BAND-AID, NEOSPORIN, STAYFREE, CAREFREE, o.b. tampon, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, cardiovascular, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, metabolic, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers various products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products to wholesalers, hospitals, and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service